Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Viscosity assessed using a tuning-fork viscometer. by Bryan S. Margulies (21492667)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Interpolated survival in mice with or without lung metastases. by Bryan S. Margulies (21492667)

Subjects:

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. by Rima Moghnieh (679199)

Subjects:

Study profile. by Rima Moghnieh (679199)

Subjects:

The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

Subjects:

Fig 3 - by Rima Moghnieh (679199)

Subjects:

The results of mediating mechanism test. by Le Zhu (1771669)

Subjects:

Balance test results. by Le Zhu (1771669)

Subjects:

Variables. by Le Zhu (1771669)

Subjects:

Results of the parallel trend test. by Le Zhu (1771669)

Subjects:

Results of the exclusion of other policies. by Le Zhu (1771669)

Subjects:

Results of robustness tests. by Le Zhu (1771669)

Subjects:

Descriptive statistical of variables. by Le Zhu (1771669)

Subjects:

The results of Bootstrap Method and Sobel Test. by Le Zhu (1771669)

Subjects:

Impact of the NAMR on CSR dimensions (E, S, G). by Le Zhu (1771669)

Subjects:

Placebo test. by Le Zhu (1771669)

Subjects: